Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""tuberculosis"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 41-60 z 253149
Tytuł:
Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice.
Autorzy:
Yang F; Department of Medicine, The University of Texas at Tyler School of Medicine, Tyler, TX, USA.; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Labani-Motlagh A; Department of Medicine, The University of Texas at Tyler School of Medicine, Tyler, TX, USA.; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Center for Discovery and Innovation, Hackensack Meridian Health, Hackensack, NJ, USA.
Bohorquez JA; Department of Medicine, The University of Texas at Tyler School of Medicine, Tyler, TX, USA.; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Moreira JD; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Ansari D; Department of Medicine, The University of Texas at Tyler School of Medicine, Tyler, TX, USA.; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Patel S; Department of Medicine, The University of Texas at Tyler School of Medicine, Tyler, TX, USA.; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Spagnolo F; Life Sciences Department, Long Island University Post, Brookville, NY, USA.
Florence J; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Vankayalapati A; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Sakai T; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Sato O; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Ikebe M; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Vankayalapati R; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Dennehy JJ; Biology Department, Queens College of The City University of New York, Flushing, NY, USA. .; The Graduate Center of The City University of New York, New York, NY, USA. .
Samten B; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA. .; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA. .
Yi G; Department of Medicine, The University of Texas at Tyler School of Medicine, Tyler, TX, USA. .; Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, TX, USA. .; Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, USA. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Mar 09; Vol. 7 (1), pp. 294. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Phage Therapy*
Tuberculosis*/therapy
Tuberculosis*/microbiology
Animals ; Mice ; Humans ; Macrophages/microbiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The collaborative framework for the management of tuberculosis and type 2 diabetes syndemic in low- and middle-income countries: a rapid review.
Autorzy:
Milice DM; Instituto Nacional de Saúde, Maputo, Mozambique. .
Macicame I; Instituto Nacional de Saúde, Maputo, Mozambique.
L Peñalvo J; Global Health Institute, University of Antwerp, Wilrijk, Belgium.; National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Mar 07; Vol. 24 (1), pp. 738. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/therapy
Tuberculosis*/epidemiology
Tuberculosis*/therapy
Tuberculosis*/diagnosis
Humans ; Developing Countries ; Syndemic ; Comorbidity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Direct TAMRA-dUTP labeling of M. tuberculosis genes using loop-mediated isothermal amplification (LAMP).
Autorzy:
Altattan B; Institute for Molecular Diagnostics und Bioanalysis (IMDB), 14476, Potsdam, Germany. .; Institute for Biochemistry and Biology, University of Potsdam, 14476, Potsdam, Germany. .
Ullrich J; Institute for Molecular Diagnostics und Bioanalysis (IMDB), 14476, Potsdam, Germany.
Mattig E; Fraunhofer Institute for Cell Therapy and Immunology-Bioanalytics and Bioprocesses (IZI-BB), 14476, Potsdam, Germany.
Poppe A; Fraunhofer Institute for Cell Therapy and Immunology-Bioanalytics and Bioprocesses (IZI-BB), 14476, Potsdam, Germany.
Martins R; Institute for Molecular Diagnostics und Bioanalysis (IMDB), 14476, Potsdam, Germany.
Bier FF; Institute for Molecular Diagnostics und Bioanalysis (IMDB), 14476, Potsdam, Germany.; Institute for Biochemistry and Biology, University of Potsdam, 14476, Potsdam, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5611. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/genetics
Tuberculosis*/diagnosis
Molecular Diagnostic Techniques*
Humans ; Nucleic Acid Amplification Techniques/methods ; DNA ; DNA Primers/genetics ; Sensitivity and Specificity
SCR Protocol:
LAMP assay
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multiple genetic loci influence vaccine-induced protection against Mycobacterium tuberculosis in genetically diverse mice.
Autorzy:
Kurtz SL; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
Baker RE; Department of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Boehm FJ; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
Lehman CC; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
Mittereder LR; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
Khan H; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
Rossi AP; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.; College of Medicine, University of Cincinatti, Cincinatti, Ohio, United States of America.
Gatti DM; The Jackson Laboratory, Bar Harbor, Maine, United States of America.
Beamer G; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
Sassetti CM; Department of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Elkins KL; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Mar 07; Vol. 20 (3), pp. e1012069. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis*/genetics
Tuberculosis*/prevention & control
Tuberculosis*/microbiology
Tuberculosis Vaccines*/genetics
Mycobacterium bovis*
Humans ; Animals ; Mice ; BCG Vaccine/genetics ; Vaccination ; Genetic Loci ; Cytokines/genetics ; Antigens, Bacterial
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diagnosis of multiple tuberculous muscle abscesses in a patient with systemic lupus erythematosus by metagenomic next-generation sequencing- a case report and literature review.
Autorzy:
Wentao L; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Shuxia X; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Guoxing Z; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Qiaoping C; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Peiran C; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Angela W; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Meirong L; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Songchao Y; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Peiying F; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. .; Department of Allergy, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 04; Vol. 24 (1), pp. 284. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Dermatomyositis*/complications
Dermatomyositis*/diagnosis
Tuberculosis*/complications
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Female ; Humans ; Adult ; Abscess/diagnosis ; Muscles ; High-Throughput Nucleotide Sequencing ; Streptomycin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessing the impact of various tuberculin PPD brands on bovine tuberculosis diagnosis.
Autorzy:
Echeverría G; Instituto de Investigación en Zoonosis-CIZ, Universidad Central del Ecuador, Quito, Ecuador.; Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, Buenos Aires, Argentina.; División Investigación y Desarrollo, BioGENA, Quito, Ecuador.
Zumárraga MJ; Instituto de Agrobiotecnología y Biología Molecular, IABIMO, INTA-CONICET, Buenos Aires, Argentina.
Proaño-Pérez F; Facultad de Medicina Veterinaria y Zootecnia, Universidad Central del Ecuador, Quito, Ecuador.
Blasco FB; One Health Research Group, Facultad de Ciencias de la Salud, Universidad de las Américas (UDLA), Quito, Ecuador.
de Waard JH; One Health Research Group, Facultad de Ciencias de la Salud, Universidad de las Américas (UDLA), Quito, Ecuador. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 02; Vol. 14 (1), pp. 5155. Date of Electronic Publication: 2024 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis, Bovine*/diagnosis
Mycobacterium bovis*
Tuberculosis*
Animals ; Female ; Cattle ; Tuberculin ; Tuberculin Test/veterinary
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling.
Autorzy:
Koele SE; Department of Pharmacy, Radboudumc Research Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands.
Dorlo TPC; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Upton CM; TASK Applied Science, Cape Town, South Africa.
Aarnoutse RE; Department of Pharmacy, Radboudumc Research Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands.
Svensson EM; Department of Pharmacy, Radboudumc Research Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Mar; Vol. 13 (3), pp. 374-385. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis, Pulmonary*/drug therapy
Humans ; Antitubercular Agents/pharmacology ; Bacterial Load ; Microbial Sensitivity Tests ; Clinical Trials, Phase II as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Toward tuberculosis elimination by understanding epidemiologic characteristics and risk factors in Hainan Province, China.
Autorzy:
Zhou C; Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44# Wenhuaxi Road, Lixia District, Jinan, Shandong, 250012, People's Republic of China.
Li T; National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Du J; Clinical Center On TB Control, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, People's Republic of China.
Yin D; Hainan Center for Disease Control and Prevention, Haikou, Hainan, 570203, People's Republic of China. .
Li X; Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44# Wenhuaxi Road, Lixia District, Jinan, Shandong, 250012, People's Republic of China. .; Research Center for Tuberculosis Control, Shandong University, Jinan, Shandong, People's Republic of China. .
Li S; Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44# Wenhuaxi Road, Lixia District, Jinan, Shandong, 250012, People's Republic of China. .
Pokaż więcej
Źródło:
Infectious diseases of poverty [Infect Dis Poverty] 2024 Feb 27; Vol. 13 (1), pp. 20. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis*/epidemiology
Tuberculosis*/prevention & control
Male ; Humans ; Female ; China/epidemiology ; Risk Factors ; Spatial Analysis ; Spatial Regression
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mesenchymal stem cells-derived extracellular vesicles for therapeutics of renal tuberculosis.
Autorzy:
Yudintceva N; Institute of Cytology of the Russian Academy of Sciences (RAS), Tikhoretsky Ave., 4, Saint Petersburg, Russia, 194064. .
Bobkov D; Institute of Cytology of the Russian Academy of Sciences (RAS), Tikhoretsky Ave., 4, Saint Petersburg, Russia, 194064.
Sulatsky M; Institute of Cytology of the Russian Academy of Sciences (RAS), Tikhoretsky Ave., 4, Saint Petersburg, Russia, 194064.
Mikhailova N; Institute of Cytology of the Russian Academy of Sciences (RAS), Tikhoretsky Ave., 4, Saint Petersburg, Russia, 194064.
Oganesyan E; Personalized Medicine Centre, Almazov National Medical Research Centre, Akkuratova Str. 2, Saint Petersburg, Russia, 197341.
Vinogradova T; Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Ligovsky Ave., 2-4, Saint Petersburg, Russia, 191036.
Muraviov A; Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Ligovsky Ave., 2-4, Saint Petersburg, Russia, 191036.; Private University St. Petersburg Medico-Social Institute, Kondratievskiy Ave., 72A, Saint Petersburg, Russia, 195271.
Remezova A; Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Ligovsky Ave., 2-4, Saint Petersburg, Russia, 191036.
Bogdanova E; Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Ligovsky Ave., 2-4, Saint Petersburg, Russia, 191036.
Garapach I; Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Ligovsky Ave., 2-4, Saint Petersburg, Russia, 191036.
Maslak O; Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Ligovsky Ave., 2-4, Saint Petersburg, Russia, 191036.
Esmedlyaeva D; Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Ligovsky Ave., 2-4, Saint Petersburg, Russia, 191036.
Dyakova M; Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Ligovsky Ave., 2-4, Saint Petersburg, Russia, 191036.
Yablonskiy P; Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Ligovsky Ave., 2-4, Saint Petersburg, Russia, 191036.
Ziganshin R; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences, Miklukho-Maklaya Str., 16/10, Moscow, Russia, 117997.
Kovalchuk S; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences, Miklukho-Maklaya Str., 16/10, Moscow, Russia, 117997.
Blum N; Kirov Military Medical Academy, Akademika Lebedeva Str., 6, Saint Petersburg, Russia, 194044.
Sonawane SH; National Institute of Technology Warangal, Warangal, 506004, India.
Sonawane A; Indian Institute of Technology Indore, Indore, 453552, India.
Behl A; Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India.
Shailja Singh; Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India.
Shevtsov M; Institute of Cytology of the Russian Academy of Sciences (RAS), Tikhoretsky Ave., 4, Saint Petersburg, Russia, 194064. .; Department of Radiation Oncology, Central Institute for Translational Cancer Research (TranslaTUM), Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany. .; School of Medicine and Life Sciences, Far Eastern Federal University, Campus 10 Ajax Bay, Russky Island, Vladivostok, Russia, 690922. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 24; Vol. 14 (1), pp. 4495. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis, Renal*/metabolism
Extracellular Vesicles*/metabolism
Mesenchymal Stem Cells*/metabolism
Animals ; Rabbits ; Cytokines/metabolism ; Anti-Inflammatory Agents/therapeutic use ; Anti-Inflammatory Agents/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains.
Autorzy:
Bua S; Research Institute of the University of Bucharest (ICUB), University of Bucharest, 050095 Bucharest, Romania.
Bonardi A; Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSA, Neurofarba Department, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
Mük GR; Faculty of Biology, University of Bucharest, Splaiul Independenței 91-95, 050095 Bucharest, Romania.; St. Stephen's Pneumoftiziology Hospital, Șoseaua Ștefan cel Mare 11, 020122 Bucharest, Romania.
Nocentini A; Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSA, Neurofarba Department, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
Gratteri P; Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSA, Neurofarba Department, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
Supuran CT; Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSA, Neurofarba Department, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Carbonic Anhydrases*/metabolism
Tuberculosis*
Humans ; Molecular Structure ; Carbonic Anhydrase Inhibitors/pharmacology ; Isoenzymes/metabolism ; Structure-Activity Relationship ; Antitubercular Agents/pharmacology ; Carbonic Anhydrase IX
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mycobacterium tuberculosis SecA2-dependent activation of host Rig-I/MAVs signaling is not conserved in Mycobacterium marinum.
Autorzy:
Serene LG; Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, United States of America.; Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, United States of America.
Webber K; Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, United States of America.; Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, United States of America.
Champion PA; Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, United States of America.; Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, United States of America.
Schorey JS; Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, United States of America.; Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 23; Vol. 19 (2), pp. e0281564. Date of Electronic Publication: 2024 Feb 23 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/genetics
Mycobacterium marinum*/genetics
Tuberculosis*/pathology
Humans ; Signal Transduction ; Macrophages/metabolism ; DEAD Box Protein 58/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diagnosis and management of tuberculosis infection in inclusion health populations in London.
Autorzy:
Gray A; University College London Hospitals, London, UK.; Hospital for Tropical Diseases, University College London Hospitals, London, UK.; Institute for Global Health, University College London, London, UK.
Surey J; University College London Hospitals, London, UK.; Institute for Global Health, University College London, London, UK.; Universidad Autonoma de Madrid, Madrid, Spain.
Veitch M; University College London Hospitals, London, UK.
Menezes D; Public Health Data Science, Institute of Health Informatics, University College London, London, UK.
Gibbons J; University College London Hospitals, London, UK.
Leonard M; University College London Hospitals, London, UK.
Sultan B; University College London Hospitals, London, UK.
Esmail H; Hospital for Tropical Diseases, University College London Hospitals, London, UK.; Institute for Global Health, University College London, London, UK.; TB Service, Whittington Hospital, London, UK.
Story A; University College London Hospitals, London, UK. .; Collaborative Centre for Inclusion Health, University College London, London, UK. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 23; Vol. 24 (1), pp. 252. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Tuberculosis*/epidemiology
Latent Tuberculosis*/diagnosis
Latent Tuberculosis*/drug therapy
Latent Tuberculosis*/epidemiology
Adult ; Humans ; Tuberculin Test ; London/epidemiology ; Interferon-gamma Release Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa.
Autorzy:
McNabb KC; Johns Hopkins University School of Nursing, 525 N Wolfe St, Baltimore, MD, 21205, USA. .; Johns Hopkins Center for Infectious Disease and Nursing Innovation, Baltimore, MD, USA. .
Bergman AJ; Johns Hopkins University School of Nursing, 525 N Wolfe St, Baltimore, MD, 21205, USA.; Johns Hopkins Center for Infectious Disease and Nursing Innovation, Baltimore, MD, USA.
Patil A; Johns Hopkins Center for Infectious Disease and Nursing Innovation, Baltimore, MD, USA.
Lowensen K; Johns Hopkins Center for Infectious Disease and Nursing Innovation, Baltimore, MD, USA.
Mthimkhulu N; Johns Hopkins Center for Infectious Disease and Nursing Innovation, Port Shepstone, Republic of South Africa.
Budhathoki C; Johns Hopkins University School of Nursing, 525 N Wolfe St, Baltimore, MD, 21205, USA.; Johns Hopkins Center for Infectious Disease and Nursing Innovation, Baltimore, MD, USA.
Perrin N; Johns Hopkins University School of Nursing, 525 N Wolfe St, Baltimore, MD, 21205, USA.
Farley JE; Johns Hopkins University School of Nursing, 525 N Wolfe St, Baltimore, MD, 21205, USA.; Johns Hopkins Center for Infectious Disease and Nursing Innovation, Baltimore, MD, USA.; Johns Hopkins TB Research Advancement Center, Baltimore, MD, USA.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Feb 23; Vol. 24 (1), pp. 578. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Rifampin*
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; South Africa/epidemiology ; Retrospective Studies ; Politics ; Antitubercular Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tuberculosis and diabetes mellitus comorbidity in an adult Ugandan population.
Autorzy:
Kibirige D; Department of Medicine, Uganda Martyrs Hospital Lubaga, Kampala, Uganda. .; Non-communicable Diseases Program, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda. .
Andia-Biraro I; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Olum R; Makerere University School of Public Health, Kampala, Uganda.
Adakun S; Adult Tuberculosis ward, Mulago National Referral and Teaching Hospital, Kampala, Uganda.
Zawedde-Muyanja S; The Infectious Diseases Institute, College of Health Sciences, Makerere University Kampala, Kampala, Uganda.
Sekaggya-Wiltshire C; The Infectious Diseases Institute, College of Health Sciences, Makerere University Kampala, Kampala, Uganda.
Kimuli I; Department of Physiology, College of Health Sciences, Makerere University Kampala, Kampala, Uganda.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 22; Vol. 24 (1), pp. 242. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus*
Tuberculosis*/complications
Tuberculosis*/diagnosis
Tuberculosis*/epidemiology
Adult ; Humans ; Female ; Male ; Uganda/epidemiology ; Glycated Hemoglobin ; Blood Glucose/metabolism ; Cross-Sectional Studies ; Comorbidity ; Prevalence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
Autorzy:
Semitala FC; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala Uganda.
Kadota JL; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda.
Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda.
Nakitende A; Infectious Diseases Research Collaboration, Kampala, Uganda.
Akello L; Infectious Diseases Research Collaboration, Kampala, Uganda.
Kunihira Tinka L; Infectious Diseases Research Collaboration, Kampala, Uganda.
Nakimuli J; Infectious Diseases Research Collaboration, Kampala, Uganda.
Ritar Kasidi J; Infectious Diseases Research Collaboration, Kampala, Uganda.
Bishop O; Infectious Diseases Research Collaboration, Kampala, Uganda.
Nakasendwa S; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Baik Y; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Patel D; The Better Lab and Department of Surgery, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Sammann A; The Better Lab and Department of Surgery, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Nahid P; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Belknap R; Denver Health and Hospital Authority and Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, Colorado, United States of America.
Kamya MR; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.
Handley MA; Center for Vulnerable Populations, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America.
Phillips PP; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Katahoire A; Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Berger CA; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Kiwanuka N; Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.
Katamba A; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
Dowdy DW; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Cattamanchi A; Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.; Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, California, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2024 Feb 20; Vol. 21 (2), pp. e1004356. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Tuberculosis*/drug therapy
Tuberculosis*/prevention & control
Latent Tuberculosis*/drug therapy
HIV Infections*/complications
HIV Infections*/drug therapy
Rifampin/*analogs & derivatives
Humans ; Isoniazid/adverse effects ; Antitubercular Agents/adverse effects ; Uganda ; Drug Therapy, Combination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nutritional status and treatment outcomes of tuberculosis in Mizan Tepi University Teaching Hospital, a five -year retrospective study.
Autorzy:
Simieneh A; Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wolkite University, Wolkite, Ethiopia.
Gashaneh S; Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Mizan Tepi University, Mizan-Aman, Ethiopia.
Dereje R; Department of Public Health, School of Public Health, College of Medicine and Health Sciences, Mizan Tepi University, Mizan-Aman, Ethiopia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 15; Vol. 19 (2), pp. e0298244. Date of Electronic Publication: 2024 Feb 15 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis*/drug therapy
Tuberculosis*/epidemiology
Tuberculosis, Pulmonary*/drug therapy
Tuberculosis, Pulmonary*/epidemiology
Malnutrition*
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Humans ; Female ; Adolescent ; Young Adult ; Adult ; Male ; Retrospective Studies ; Nutritional Status ; Cross-Sectional Studies ; Universities ; Treatment Outcome ; Hospitals, University ; Hospitals, Teaching ; Ethiopia/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Performance evaluation of Truenat MTB and Truenat MTB-RIF DX assays in comparison to gene XPERT MTB/RIF ultra for the diagnosis of pulmonary tuberculosis in Uganda.
Autorzy:
Ssengooba W; Department of Medical Microbiology, Makerere University, Kampala, Uganda. .; Makerere University Lung Institute, Kampala, Uganda. .; Biomedical Research Center, Makerere University, Kampala, Uganda. .
Katamba A; Department of Medicine, School of Medicine, Clinical Epidemiology and Biostatistics Unit, Makerere University, Kampala, Uganda.; Uganda TB Implementation Research Consortium, Kampala, Uganda.
Sserubiri J; Department of Medical Microbiology, Makerere University, Kampala, Uganda.; Makerere University Lung Institute, Kampala, Uganda.
Semugenze D; Department of Medical Microbiology, Makerere University, Kampala, Uganda.; Makerere University Lung Institute, Kampala, Uganda.
Nyombi A; Ministry of Health, National Tuberculosis, and Leprosy Programme, Kampala, Uganda.
Byaruhanga R; Ministry of Health, National Tuberculosis, and Leprosy Programme, Kampala, Uganda.
Turyahabwe S; Ministry of Health, National Tuberculosis, and Leprosy Programme, Kampala, Uganda.
Joloba ML; Department of Medical Microbiology, Makerere University, Kampala, Uganda.; Biomedical Research Center, Makerere University, Kampala, Uganda.; Ministry of Health, National Tuberculosis, and Leprosy Programme, Kampala, Uganda.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 13; Vol. 24 (1), pp. 190. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/genetics
Tuberculosis, Pulmonary*/diagnosis
Humans ; Rifampin ; Uganda ; Cross-Sectional Studies ; Sputum ; Sensitivity and Specificity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mathematical model of oxygen, nutrient, and drug transport in tuberculosis granulomas.
Autorzy:
Datta M; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana, United States of America.
Kennedy M; Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana, United States of America.
Siri S; Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana, United States of America.
Via LE; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health, Bethesda, Maryland, United States of America.
Baish JW; Department of Biomedical Engineering, Bucknell University, Lewisburg, Pennsylvania, United States of America.
Xu L; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Dartois V; Center for Discovery and Innovation, Hackensack Meridian School of Medicine, Hackensack Meridian Health, Nutley, New Jersey, United States of America.
Barry CE 3rd; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health, Bethesda, Maryland, United States of America.
Jain RK; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2024 Feb 09; Vol. 20 (2), pp. e1011847. Date of Electronic Publication: 2024 Feb 09 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis*/drug therapy
Tuberculosis*/pathology
Mycobacterium tuberculosis*/metabolism
Animals ; Mice ; Rabbits ; Oxygen/metabolism ; Granuloma/pathology ; Disease Models, Animal ; Nutrients
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diagnostic accuracy of Lipoarabinomannan detection by lateral flow assay in pleural tuberculosis.
Autorzy:
Mohapatra A; Department of Microbiology, All India Institute of Medical Sciences Raipur, Tatibandh, G E Road, Raipur, 492099, India.
Gaikwad U; Department of Microbiology, All India Institute of Medical Sciences Raipur, Tatibandh, G E Road, Raipur, 492099, India. .
Ganga RT; Department of Pulmonary Medicine, All India Institute of Medical Sciences, Raipur Tatibandh, G E Road, Raipur, 492099, India.
Sharma P; Department of Microbiology, Shri Balaji Institute of Medical Sciences, Mowa, Raipur, Chhattisgarh, 492001, India.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 09; Vol. 24 (1), pp. 178. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis, Pleural*/diagnosis
Tuberculosis, Pleural*/microbiology
HIV Infections*
Humans ; Cross-Sectional Studies ; Sensitivity and Specificity ; Lipopolysaccharides/urine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis.
Autorzy:
Wenlu Y; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Xia Z; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Chuntao W; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Qiaolin Y; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Xujue X; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Rong Y; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Dan S; Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Xi Y; Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Bin W; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 07; Vol. 24 (1), pp. 169. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Pulmonary*/diagnosis
Tuberculosis, Pulmonary*/drug therapy
Mycobacterium tuberculosis*
Humans ; Female ; Antitubercular Agents/therapeutic use ; Sputum ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 41-60 z 253149

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies